PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $877 | -0.9% | 50,575 | +3.5% | 0.00% | 0.0% |
| Q2 2023 | $885 | +47.7% | 48,850 | +117.1% | 0.00% | 0.0% |
| Q1 2023 | $599 | +52.4% | 22,500 | +10.6% | 0.00% | 0.0% |
| Q4 2022 | $393 | -99.9% | 20,350 | +4.4% | 0.00% | 0.0% |
| Q3 2022 | $407,000 | +84.2% | 19,500 | -29.4% | 0.00% | – |
| Q2 2022 | $221,000 | -28.0% | 27,613 | -36.9% | 0.00% | – |
| Q1 2022 | $307,000 | -27.1% | 43,771 | +40.5% | 0.00% | – |
| Q4 2021 | $421,000 | +52.5% | 31,149 | +90.5% | 0.00% | – |
| Q3 2021 | $276,000 | -56.3% | 16,353 | -24.6% | 0.00% | -100.0% |
| Q2 2021 | $632,000 | -14.0% | 21,691 | +16.0% | 0.00% | 0.0% |
| Q1 2021 | $735,000 | +240.3% | 18,700 | +96.8% | 0.00% | – |
| Q4 2020 | $216,000 | +300.0% | 9,500 | +295.8% | 0.00% | – |
| Q3 2020 | $54,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |